Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

LAVA THERAPEUTICS B.V.

(LVTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.

Number of employees : 31 people.
Sales per Business
20192020Delta
Novel Bispecific Antibodies--3.63100%-
USD in Million
Sales per region
20192020Delta
The Netherlands--3.63100%-
USD in Million
Managers
Name Title Age Since
Stephen Allen Hurly President, Chief Executive Officer & MD 52 2019
Edward F. Smith Chief Financial Officer 48 2021
Benjamin Winograd, Dr. Chief Medical Officer 59 2020
Hans van der Vliet, Dr. Chief Scientific Officer 46 2017
Paul W. H. I. Parren, Dr. MD, EVP, Head-Research & Development 56 2018
Karen J. Wilson Independent Director 57 2021
Amy Garabedian Secretary & General Counsel - 2021
Ton Adang, Dr. Chief Development Officer 59 2017
Peter Ros Vice President-Finance 48 2020
Members of the board
Name Title Age Since
Kapil Dhingra, Dr. Chairman 60 2021
Erik J. van den Berg Non-Executive Director 47 2021
Stefan Luzi, Dr. Non-Executive Director 36 2021
Guido Magni, Dr. Non-Executive Director 66 2021
JoŰl Jean Pierre Jean-Mairet, Dr. Non-Executive Director 48 2021
Nanna Liebach LŘneborg, Dr. Non-Executive Director 44 2021
Laia Crespo Martin, Dr. Member-Supervisory Board - -
Karen J. Wilson Independent Director 57 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 25,114,162 16,979,705 67.6% 0 0.0% 67.6%
Shareholders
NameEquities%
Gilde Healthcare Partners BV 5,421,170 21.4%
Versant Venture Management LLC 3,407,157 13.4%
Novo Holdings A/S (Investment Company) 3,327,312 13.1%
Redmile Group LLC 2,824,409 11.1%
Sanofi 1,919,455 7.57%
Ysios Capital Partners SGEIC SA 1,190,527 4.70%
Merck & Co., Inc. 1,082,679 4.27%
Nicholas Investment Partners LP 814,840 3.21%
Nantahala Capital Management LLC 381,227 1.50%
Monashee Investment Management LLC 265,000 1.05%
Company contact information
LAVA Therapeutics NV
Yalelaan 60
Utrecht, Noord-Brabant 3584 CM

Phone : +31.63.000.30.35
Web : http://www.lavatherapeutics.com
Sector Other Biotechnology & Medical Research
1st jan.Capi. (M$)
LAVA THERAPEUTICS B.V.0.00%139
MODERNA, INC.238.47%141 980
LONZA GROUP AG23.98%57 809
IQVIA HOLDINGS INC.38.25%47 462
CELLTRION, INC.-26.60%30 059
SEAGEN INC.-12.42%27 907
CUREVAC N.V.-39.24%21 497
ALNYLAM PHARMACEUTICALS, INC.37.68%21 034
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.62.86%20 449
PHARMARON BEIJING CO., LTD.72.12%20 226
ICON PUBLIC LIMITED COMPANY24.77%19 385
BIO-TECHNE CORPORATION51.86%18 755
HANGZHOU TIGERMED CONSULTING CO., LTD-2.34%18 276
INCYTE CORPORATION-11.07%17 011
PPD, INC.34.78%16 203
NOVAVAX, INC.60.82%13 285
QIAGEN N.V.-0.11%12 062
PRA HEALTH SCIENCES, INC.0.00%10 965
INTELLIA THERAPEUTICS, INC.160.75%10 305
BACHEM HOLDING AG51.71%9 267
SYNEOS HEALTH, INC.31.62%9 265